A Pilot Trial of Adding Maraviroc to Suppressive Antiretroviral Therapy for Suboptimal CD4(+) T-Cell Recovery Despite Sustained Virologic Suppression: ACTG A5256

Background. Despite viral suppression, antiretroviral therapy (ART) does not restore CD4(+) T-cell counts in many patients infected with human immunodeficiency virus type 1 (HIV-1). Methods. In a single-arm pilot trial involving ART recipients with suppressed plasma levels of HIV-1 RNA for at least...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Wilkin, Timothy J., Lalama, Christina M., McKinnon, John, Gandhi, Rajesh T., Lin, Nina, Landay, Alan, Ribaudo, Heather, Fox, Lawrence, Currier, Judith S., Mellors, John W., Gulick, Roy, Tenorio, Allan R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2012
Konular:
Major Articles and Brief Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3491731/
https://ncbi.nlm.nih.gov/pubmed/22740718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jis376
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller